Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size

M Licka1, R Zimmermann, J Zehelein

  • 1Department of Cardiology, University of Heidelberg, Heidelberg, Germany.

Insights

A single troponin T measurement 72 hours after myocardial infarction is superior for estimating infarct size compared to traditional markers like CK, CK-MB, and LDH. This method is independent of reperfusion therapy, offering a more precise assessment of irreversible myocardial damage.

Area of Science:

  • Cardiology
  • Biomarkers
  • Diagnostic Imaging

Background:

  • Acute myocardial infarction (MI) leads to the release of cardiac biomarkers.
  • Troponin T is released longer than other markers like creatine kinase (CK), CK-MB, and lactate dehydrogenase (LDH).
  • Late troponin T release is less influenced by early coronary reperfusion after MI.

Purpose of the Study:

  • To evaluate the precision of a single troponin T measurement 72 hours post-MI.
  • To compare troponin T measurements with standard scintigraphic and enzymatic methods for estimating myocardial infarct size.

Main Methods:

  • Quantitative single photon emission computed tomography (SPECT) thallium-201 scintigraphy was used.
  • 37 patients were studied 2-3 weeks after MI, divided into groups with and without early coronary reperfusion.
  • Reperfusion was achieved via thrombolytic therapy, percutaneous transluminal coronary angioplasty, or both.

Main Results:

  • A significant correlation was found between troponin T concentrations at 72 hours and the extent of irreversible myocardial damage.
  • This correlation held true regardless of early coronary reperfusion status.
  • Troponin T measurements correlated significantly with peak CK, CK-MB, and LDH concentrations.

Conclusions:

  • A single troponin T measurement 72 hours after MI is a superior method for estimating myocardial infarct size.
  • This method is independent of reperfusion status, unlike peak CK, CK-MB, or LDH measurements.
  • Troponin T offers a more precise assessment of irreversible myocardial damage compared to serial enzymatic determinations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...